주식/증권
📈 긍정적
관련 뉴스
Journey Medical anticipates Emrosi addition to a national plan with over 25M lives beginning 2027
11/13/2026
Lulu’s outlines $5M annualized savings amid revised 2026 outlook and financing talks
11/13/2026
Relmada outlines NDV-01 IND submission by year-end 2026 with cash runway through 2029
11/13/2026
Codexis reiterates $72M-$76M 2026 revenue outlook while extending cash runway through 2028
11/13/2026